financetom
Business
financetom
/
Business
/
Rev Exploration Commencing Drill Program on Aden Dome Project in Q1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rev Exploration Commencing Drill Program on Aden Dome Project in Q1
Mar 11, 2026 12:57 AM

10:33 AM EST, 01/19/2026 (MT Newswires) -- Rev Exploration ( REVFF ) said Monday that it is launching a drilling program in the first quarter on its flagship Aden Dome project in Alberta along the Montana border after closing private placements totaling C$5.8 million.

The Aden Dome is considered highly prospective for natural hydrogen and associated gases, and is located along a geological belt that extends from Saskatchewan into Montana.

The company also said it has secured a land package in Northern Quebec's Chibougamau Gold Camp totaling about 52,000 hectares or 520 square kilometers, including the drill-ready JMW Property.

In addition, Rev said it has increased its ownership in MAX Power (MAXX.CN) to six million shares, representing a 5.0% stake on a non-diluted basis, after exercising two million warrants of MAX Power.

"By increasing our ownership position, we are strengthening an asset-backed investment that we believe has the potential to meaningfully enhance shareholder value at REV," chief executive officer Jordan Potts said. "This transaction underscores our strategy of using partnerships and disciplined capital allocation to create upside for our shareholders while maintaining focus on our core exploration initiatives."

Price: 0.72, Change: +0.08, Percent Change: +12.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fengate Private Equity and Sweets from the Earth announce partnership to propel next stage of growth
Fengate Private Equity and Sweets from the Earth announce partnership to propel next stage of growth
Sep 17, 2025
TORONTO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Fengate Private Equity, a division of Fengate Asset Management (“Fengate”), today announced a partnership with Sweets from the Earth (or “the Company”), a leading manufacturer of 100% plant-based, allergy-friendly sweet baked goods, to further support the growth of the business throughout North America. Fengate is managing this investment on behalf of the LiUNA...
I Squared Capital Acquires Majority Stake in ENTEK to Reshore Critical U.S. Battery Manufacturing
I Squared Capital Acquires Majority Stake in ENTEK to Reshore Critical U.S. Battery Manufacturing
Sep 17, 2025
$800 Million Investment Powers America’s First Gigafactory for Lithium-Ion Separators, Strengthening American Supply Chains and Economic Security MIAMI--(BUSINESS WIRE)-- I Squared Capital (“I Squared”), a leading global infrastructure investment manager, today announced it has signed a definitive agreement to acquire a majority equity interest in ENTEK Technology Holdings LLC (“ENTEK”), a leading global manufacturer of battery separators. I Squared’s...
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
Sep 17, 2025
EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ( XOMA ) , a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of HilleVax, Inc. ( HLVX ) (“HilleVax”) common stock...
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, From Thompson Street Capital Partners
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, From Thompson Street Capital Partners
Sep 17, 2025
HOPKINTON, Mass.--(BUSINESS WIRE)-- Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyout[1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics (“Isto”) from Thompson Street Capital Partners (“TSCP”). TSCP will retain a minority stake, alongside Isto Biologics’ management team. Founded in 2016, Isto Biologics is a regenerative MedTech company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved